Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![UTEX_io Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1400373496543318020.png) utex.io [@UTEX_io](/creator/twitter/UTEX_io) on x 16.1K followers
Created: 2025-06-16 16:44:26 UTC

Sarepta Therapeutics -XX%

The biotech company said a second Duchenne muscular dystrophy patient taking its drug Elevidys died of acute liver failure.

Trade $SRPT:


![](https://pbs.twimg.com/media/GtlEwxqa0AAn3br.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1934653306191626271/c:line.svg)

**Related Topics**
[$srpt](/topic/$srpt)
[sarepta therapeutics](/topic/sarepta-therapeutics)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/UTEX_io/status/1934653306191626271)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

UTEX_io Avatar utex.io @UTEX_io on x 16.1K followers Created: 2025-06-16 16:44:26 UTC

Sarepta Therapeutics -XX%

The biotech company said a second Duchenne muscular dystrophy patient taking its drug Elevidys died of acute liver failure.

Trade $SRPT:

XXX engagements

Engagements Line Chart

Related Topics $srpt sarepta therapeutics sarepta therapeutics inc stocks healthcare

Post Link

post/tweet::1934653306191626271
/post/tweet::1934653306191626271